Brugada Ablation of VF Substrate Ongoing MultiCenter Registry (BRAVO)

Pacific Rim Electrophysiology Research Institute

Status: Completed

Conditions: Brugada Syndrome

Treatments: Procedure: Catheter Ablation

Study type: Observational

Funder types: Other

Identifiers

NCT04420078

BRAVO Registry

Details and patient eligibility

About

Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.

Full description

Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators exclude patients who were lost to follow up in the outpatient clinic.

Enrollment: 159 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.

Exclusion criteria

• Patients who will not commit to regular follow up.

Trial design

159 participants in 1 patient group

CA BrS

Description:

Symptomatic BrS patients who underwent catheter ablation of the BrS/VF substrate

Treatment:

Procedure: Catheter Ablation